Search Results 421-430 of 16832 for Linaclotide

  1. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

    Pembrolizumab has been approved for treatment of patients with melanoma but has not been proven to be safe or helpful in patients with pancreatic cancer and is ...

  2. Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck - Mayo Clinic

    Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by ...

  3. Lobular carcinoma in situ (LCIS) - Doctors and departments - Mayo Clinic

    If a breast biopsy reveals you have LCIS, your risk of breast cancer is increased. Learn how you can reduce your risk through medications and other ...

  4. A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) - Mayo Clinic

    This (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in ...

  5. Selinexor in Advanced Liposarcoma - Clinical Trials

    This is a randomized, multicenter, double-blind, placebo-controlled, Phase 2-3 study of patients diagnosed with advanced unresectable dedifferentiated ...

  6. Colon Melanoma Clinical Trials

    This phase I trial studies the side effects and best dose of paclitaxel albumin-stabilized nanoparticle formulation and bevacizumab in treating patients with ...

  7. A Study to Evaluate Setmelanoitide to Treat Patients with Rare Genetic Disorders of Obesity - Mayo Clinic

    The purpose of this study is to explore the impact of Setmelanotide on obesity in patients with various specific rare genetic mutations. Participation ...

  8. Licensed technology - Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

    The Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., at Mayo Clinic has developed a transformed sinusoidal endothelial cell ...

  9. Clinical trials - Oncology (Medical)

    The use of this lotion is considered investigational since it hasn't been studied in lymphoma cancer patients with low magnesium levels before; however, the FDA ...

  10. A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non-Squamous Non-Small Cell Lung Cancer - Mayo Clinic

    A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non- ...